Business Categories Reports Podcasts Events Awards Webinars
Contact My Account About

Bioscience Company Kaffe Bueno Secures €6.2 Million in Series A

Published February 7, 2024
Published February 7, 2024
Yohan Marion via Unsplash

Kaffe Bueno, a leading Danish bioscience company known for its innovative approach to valorizing coffee by-product lands €6.2 million ($6.6 million) Series A funding round led by global biorefinery leader Borregaard.

WHO: Kaffe Bueno was founded in 2016 by three Colombian entrepreneurs—Camilo Fernandez, Alejandro Franco, and Juan Medina. Growing up in Colombia, all were familiar with coffee as a health-enhancing plant that could be used for so much more than just a caffeinated beverage.

Today, Kaffe Bueno is a forerunner within sustainable biotech that upcycles coffee by-products into innovative active and functional ingredients for a wide range of everyday products in the industries responsible for society’s well-being. The first focus is the personal care industry where active ingredients such as Kaffoil, Kaffage, and Kaffair are already launched in the market.

WHY: The financial injection marks a pivotal moment in Kaffe Bueno's growth trajectory and validates the investors' belief in the company’s vision and technology. Borregaard, a global leader in biomass refining and advanced environmentally friendly biochemicals, has shown an interest in Kaffe Bueno's unique approach to coffee biorefining and increased market demand for high-performing biobased solutions. 

IN THEIR OWN WORDS: “Kaffe Bueno’s approach to upcycling of coffee by-products into high-value products for global niche markets aligns well with Borregaard’s business model. We are impressed by what it has achieved so far and look forward to being part of its ongoing journey. We realize that it will take time to scale up and fine-tune production and establish a global business, but we see this as an interesting opportunity with potential synergies between the two companies in several functions,” says Per A. Sørlie, President and CEO of Borregaard.

"It is amazing to receive the support of such a strong partner and leader in the refining of biomass,” says Juan Pablo Medina, CEO of Kaffe Bueno. “This investment is a clear testament of support for our efficient biorefinery technology and all the different novel applications/products we have developed from coffee side streams. With Borregaard’s expertise in biorefinery operations and access to key markets and customers, our path to a commercial size biorefinery is clearer than ever.”

DETAILS:

  • Kaffe Bueno landed a €6.2 million ($6.6 million) Series A funding round led by Borregaard with the participation of the round led by Borregaard, with participation by EIC/EIB and existing investors PINC (venture arm of Finnish Paulig), The Yield Lab, EIFO (Export and Investment Fund of Denmark), and Dalgaard Group.
  • In 2021, the team received a $2.8 million (€2.6 million) grant from the European Innovation Council, which it used to build the first coffee biorefinery.
  • In 2020, Kaffe Bueno received €1.1 million ($1.2 million) from, PINC (Paulig Group venture capital, FI), Vækstfonden (DK), The Yield Lab (IE), and a Danish business angel.
×

2 Article(s) Remaining

Subscribe today for full access